BRIEF-Cytokinetics starts phase 3 clinical trial of omecamtiv mecarbil
December 01, 2016 at 07:51 AM EST
* Cytokinetics announces start of galactic-hf, a phase 3 clinical trial of omecamtiv mecarbil
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.